This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
UnitedHealth Group (UNH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $295.09 in the latest trading session, marking a +0.85% move from the prior day.
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $290.47, moving -0.53% from the previous trading session.
6 Trade-Proof Sector ETFs to Follow if No Deal is Cracked
by Sanghamitra Saha
These sector ETFs are almost trade-resistant and thus unlikely to suffer if no deal is cracked before Dec 15.
UnitedHealth (UNH) to Buy Diplomat, Expand Pharmacy Services
by Sapna Bagaria
UnitedHealth (UNH) inks an agreement to acquire Diplomat to expand its in-house pharmacy benefit management business.
UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $277.54, marking a -0.95% move from the previous day.
UnitedHealth (UNH) Provides Guidance for 2020, Shares Fall
by Sapna Bagaria
UnitedHealth's (UNH) guidance for 2020 indicates revenue and earnings growth but it is believed to be conservative, leading to a decline in shares.
Molina Healthcare Wins Kentucky Medicaid Managed Care Deal
by Zacks Equity Research
Molina Healthcare's (MOH) Kentucky Medicaid Managed Care contract win to aid 2020 premium revenues.
Company News for Dec 4, 2019
by Zacks Equity Research
Companies In The News Are: UNH,PEP,CLF,AKS,BOLD.
Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FTCS
UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $276.90, marking a -0.99% move from the previous day.
Zacks Value Trader Highlights: Apple, Disney, Home Depot, UnitedHealth and Union Pacific
by Zacks Equity Research
Zacks Value Trader Highlights: Apple, Disney, Home Depot, UnitedHealth and Union Pacific
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $280.67 in the latest trading session, marking a -0.26% move from the prior day.
When to Sell a Value Stock
by Tracey Ryniec
Value investors face a conundrum as stocks keep hitting new all-time highs. Do you keep your former value stocks or do you cash them in?
UnitedHealth Group to Enhance its Medicare Advantage Network
by Zacks Equity Research
UnitedHealth Group (UNH) partners Walgreens to provide better access to MA members.
Walgreens, UnitedHealthcare Team Up to Boost Medicare Services
by Zacks Equity Research
Walgreens (WBA) partners with UnitedHealthcare to further strengthen the Medicare coverage for its customers.
5 Corporate Giants That Popped After Latest Earnings Release
by Nalak Das
A few corporate behemoths that reported their last earnings results less than five weeks ago, popped after releasing earnings results.
Stock Market News for Nov 18, 2019
by Zacks Equity Research
Benchmarks closed at record highs on Friday on U.S.-China trade deal hopes in spite of mixed economic data.
UnitedHealth (UNH) Looks Good: Stock Adds 5.3% in Session
by Zacks Equity Research
UnitedHealth (UNH) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Healthcare Stocks in Focus on Price Transparency Rule
by Sapna Bagaria
Hospital stocks gain from a less-than-expected strict price transparency rule and health insurers' optimism on a likely rise in profitability from a low-cost plan.
US Equities Continue to March Steadily Higher
by David Borun
Positive developments in international trade and healthcare puch stocks to another round of new record highs.
UnitedHealth (UNH) Up 7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
UnitedHealth (UNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights: Mastercard, UnitedHealth, Merck, Qualcomm and CVS Health
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Mastercard, UnitedHealth, Merck, Qualcomm and CVS Health
More Record Highs in a Broadly Positive Week for US Equities
by David Borun
Easing of trade concerns and a steepening yield curve supporting steady share appreciation
Genesis Healthcare's (GEN) Q3 Earnings Beat, Improve Y/Y
by Zacks Equity Research
Genesis Healthcare's (GEN) third-quarter results reflect same store occupancy growth, partly offset by lower revenues.
Top Analyst Reports for Mastercard, UnitedHealth & Merck
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Mastercard (MA), UnitedHealth Group (UNH) and Merck (MRK).